New World Investor – Technology Stocks and More » FDA

Oct

24

Flash Alert – BioCryst Gets EUA – 10.24.09

Michael Murphy Flash Alerts 165 comments

Read the rest of this entry

2009 flu pandemic, Antiviral drug, Emergency Use Authorization, FDA, Food and Drug Administration, Oseltamivir, peramivir, United States Department of Health and Human Services

Oct

19

Flash Alert – Amgen’s Prolia Delayed – 10.19.09

Michael Murphy Flash Alerts 9 comments

Amgen’s Prolia (denosumab) Delayed

Read the rest of this entry

Amgen, AMGN, Denosumab, FDA, Osteoporosis, Risk management

Sep

20

Flash Alert – ARNA Posted to Seeking Alpha – 9.20.09

Michael Murphy Flash Alerts 38 comments

Read the rest of this entry

Anti-obesity medication, Arena Pharmaceuticals, ARNA, Clinical trial, Contrave, European Union, FDA, lorcaserin, Obesity, OREX, Orexigen Therapeutics, Qnexa, Sanofi-Aventis, Vivus, VVUS

Sep

17

Radar Report – 9.17.09

Michael Murphy Radar Reports 78 comments

Read the rest of this entry

Anti-obesity medication, FDA, Health, Obesity

Sep

02

Flash Alert – 9.2.09 – Raising BCRX Buy Limit

Michael Murphy Flash Alerts 67 comments

The bear raid on BioCryst (BCRX) ran

Read the rest of this entry

Exponential growth, FDA, Infectious disease, Swine influenza, Twitter, United States, US, US Food and Drug Administration

Aug

14

Flash Alert – BCRX Files Two Phase III Trials

Michael Murphy Flash Alerts 55 comments

BioCryst (BCRX) has filed for two Phase III clinical trials for peramivir,

Read the rest of this entry

Clinical trial, FDA, Health, Infectious disease, Influenza, Oseltamivir, Statistical significance, US Food and Drug Administration